These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients. Te Dorsthorst MJ, Heesakkers JPFA, van Balken MR. Neurourol Urodyn; 2020 Feb; 39(2):702-706. PubMed ID: 31845404 [Abstract] [Full Text] [Related]
3. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder. Salatzki J, Liechti MD, Spanudakis E, Gonzales G, Baldwin J, Haslam C, Pakzad M, Panicker JN. BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801 [Abstract] [Full Text] [Related]
4. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Martin-Garcia M, Crampton J. Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384 [Abstract] [Full Text] [Related]
6. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541 [Abstract] [Full Text] [Related]
9. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation. Del Río-Gonzalez S, Aragon IM, Castillo E, Milla-España F, Galacho A, Machuca J, Lara MF, Herrera-Imbroda B. Urology; 2017 Oct; 108():52-58. PubMed ID: 28687483 [Abstract] [Full Text] [Related]
10. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement. Brandon C, Oh C, Brucker BM, Rosenblum N, Ferrante KL, Smilen SW, Nitti VW, Pape DM. Urology; 2021 Feb; 148():93-99. PubMed ID: 33358753 [Abstract] [Full Text] [Related]
11. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, Ozden H, Ozisik Karaman H. Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213 [Abstract] [Full Text] [Related]
12. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO. Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904 [Abstract] [Full Text] [Related]
13. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder. Tudor KI, Seth JH, Liechti MD, Ochulor J, Gonzales G, Haslam C, Fox Z, Pakzad M, Panicker JN. Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101 [Abstract] [Full Text] [Related]
14. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Rostaminia G, Chang C, Pincus JB, Sand PK, Goldberg RP. Int Urogynecol J; 2019 Oct; 30(10):1735-1745. PubMed ID: 30498931 [Abstract] [Full Text] [Related]
16. Factors Associated With Long-Term Use of Percutaneous Tibial Nerve Stimulation for Management of Overactive Bladder Syndrome. Gordon T, Merchant M, Ramm O, Patel M. Female Pelvic Med Reconstr Surg; 2021 Jul 01; 27(7):444-449. PubMed ID: 32649325 [Abstract] [Full Text] [Related]
17. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo P. J Urol; 2013 Aug 01; 190(2):673-7. PubMed ID: 23422257 [Abstract] [Full Text] [Related]
18. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study. Scaldazza CV, Morosetti C, Giampieretti R, Lorenzetti R, Baroni M. Int Braz J Urol; 2017 Aug 01; 43(1):121-126. PubMed ID: 28124534 [Abstract] [Full Text] [Related]